retatrutide clinical trial safety A new from Eli Lilly and Company suggests its experimental triple hormone drug, retatrutide, could become one of the next major medications in the rapidly growing weight loss and diabetes Integrated Clinical Trial Services |

'I chose quality of life over weight loss' For most of her life, Reilly has struggled with her weight and with PCOS, which often comes with insulin resistance

While compounded therapies are rarely covered by commercial insurance, Ivim Health accepts HSA and FSA cards at checkout, making it easier to use pre-tax healthcare dollars for your monthly stack

Most common GLP-1 side effects The most common side effects of Semaglutide (GLP-1) medications include nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar) in patients with type 2 diabetes, flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)

I have some patients who are seeing me from locations where it would have taken them hours to drive in for a clinic visit